Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Finished Goods (2022 - 2026)

HeartSciences (HSCS) has disclosed Finished Goods for 4 consecutive years, with $22221.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods fell 1.59% year-over-year to $22221.0, compared with a TTM value of $22221.0 through Oct 2025, down 1.59%, and an annual FY2025 reading of $44069.0, up 95.16% over the prior year.
  • Finished Goods was $22221.0 for Q4 2025 at HeartSciences, down from $44069.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $44069.0 in Q2 2025 and bottomed at $22221.0 in Q4 2025.
  • Average Finished Goods over 4 years is $28665.5, with a median of $28662.0 recorded in 2022.
  • The sharpest move saw Finished Goods dropped 21.22% in 2024, then skyrocketed 95.16% in 2025.
  • Year by year, Finished Goods stood at $28663.0 in 2022, then decreased by 0.0% to $28662.0 in 2023, then decreased by 21.22% to $22581.0 in 2024, then dropped by 1.59% to $22221.0 in 2025.
  • Business Quant data shows Finished Goods for HSCS at $22221.0 in Q4 2025, $44069.0 in Q3 2025, and $44069.0 in Q2 2025.